Romania has a pharmaceutical market of 5.47 billion lei (1,550 million Euro) in 2006, where the market for prescription drugs was about 4.58 billion lei, of which 80 percent are financed by health insurance. Government policies have been more liberal than in other countries in the region, allowing easy market access and access to funding with relatively high reimbursement rates for new drugs. This creates pressure on the financing system (health insurance)...
See More
DETAILS
-
2013/01/01
-
Working Paper
-
81021
-
1
-
1
-
2013/09/12
-
Disclosed
-
Romania - Pharmaceutical sector analysis
-
pharmaceutical sector
DOWNLOADS
COMPLETE REPORT
Official version of document (may contain signatures, etc)
-
Total Downloads** : 3690
*The text version is uncorrected OCR text and is included solely to benefit users with slow connectivity.
Citation
Seiter,Andreas.
Romania - Pharmaceutical sector analysis (English). Washington DC ; World Bank. http://documents.worldbank.org/curated/en/763671468294308875